Sunday, August 24, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Insiders Show Strong Belief in Charles Colvard Ltd

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
TMUS stock news
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Insiders within Charles & Colvard, Ltd. have recently been increasing their holdings, showing strong belief in the company’s potential. Director Ollin B Sykes bought 44,940 shares at an average price of $0.38, totaling approximately $17,287. President and CEO Don O’Connell also acquired 30,000 shares at an average price of $0.34, costing around $10,164. These insider trades indicate optimism for the future of Charles & Colvard, even after the company reported a quarterly loss of 9 cents per share on February 13th.

CTHR Stock Price Jumps 3.38% on March 4, 2024: Is This the Start of a Trend?

On March 4, 2024, CTHR stock experienced a positive price momentum, with shares increasing by $0.01 since the previous market close. This represents a 3.38% rise in the stock price, opening at $0.36, which was $0.01 higher than its previous close.

Investors should take note of the price movement on March 4 and consider whether this short-term increase is indicative of a larger trend or simply a temporary fluctuation. It is important to conduct thorough research and analysis before making any investment decisions regarding CTHR or any other stock.

CTHR Stock Performance Under Scrutiny: Revenue Decline and Net Loss Reported

On March 4, 2024, the stock performance of CTHR, or Charles & Colvard, was under scrutiny as the company released its financial data for the past year and the most recent quarter. According to CNN Money, CTHR reported a total revenue of $29.95 million for the past year, which was a decrease of 30.5% compared to the previous year. The total revenue for the most recent quarter was $7.91 million, showing a significant increase of 59.61% since the last quarter.

In terms of net income, CTHR reported a net loss of $19.58 million for the past year, which was a substantial decrease of 924.83% compared to the previous year. The net loss for the most recent quarter was $2.87 million, representing a decrease of 12.86% since the last quarter.

Earnings per share (EPS) for CTHR were also negatively impacted, with the company reporting an EPS of -$0.64 for the past year, a decrease of 950.4% compared to the previous year. The EPS for the most recent quarter was -$0.09, showing a decrease of 13.19% since the last quarter.

Overall, the financial data released by CTHR on March 4, 2024, painted a mixed picture of the company’s performance. Investors and analysts will be closely monitoring CTHR’s future financial reports to see if the company can turn around its negative performance and improve its bottom line.

Tags: CTHR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Charts for stock trading

Analyst Evaluations and Price Targets for Analog Devices NASDAQ ADI

Entertainment Trading online

Netflixs Triumph A ForwardThinking Approach to Streaming Success

Entertainment Markets and money

Disneys Strategic Initiatives for Success and Sustainability

Recommended

Biotechnology Stock Exchange

Perions Groundbreaking Partnership with Wayio Expanding into Chinas Booming Digital Market

1 year ago
Mining technology

Webull Corporation to Go Public through SPAC Merger A GameChanging Move in Digital Investing

1 year ago

MindMeds MM120 Program Receives FDA Breakthrough Therapy Designation for Generalized Anxiety Disorder

1 year ago

Supernus Pharmaceuticals Wins Patent Infringement Case Secures Exclusivity for Trokendi XR

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN Apple AVGO BA C CELH COIN Coinbase COST CRWD DELL DIS DWAC Eli Lilly EQT GM GRFS IBM INTC JPM LLY META Micron MSFT NFLX NIO NVDA NVO PARA PLTR PLUG Robinhood SMCI Strategy TGT TSLA UNH VZ
No Result
View All Result

Highlights

Can Nike’s Jordan Brand Reclaim Its Air?

Rafael Holdings Shares Stage a Tentative Rebound After Steep Declines

B&G Foods Stock: Can Strategic Shifts Offset Persistent Headwinds?

Gilead Sciences: Navigating Setbacks and Strategic Investments

Fiserv Faces Class Action Lawsuit Over Business Practices

Oxford Lane Capital Shares Tumble on Unexpected Earnings Shortfall

Trending

Procter & Gamble Stock
Stocks

Insider Selling Spree Raises Questions at Procter & Gamble

by Dieter Jaworski
August 24, 2025
0

A significant wave of insider selling activity at Procter & Gamble is drawing investor scrutiny. Corporate leaders...

Oracle Stock

Oracle’s AI Ambition: Market Optimism Meets Investor Skepticism

August 24, 2025
Salesforce Stock

Activist Investor Targets Salesforce Amid Market Challenges

August 24, 2025
Nike Stock

Can Nike’s Jordan Brand Reclaim Its Air?

August 24, 2025
Rafael Stock

Rafael Holdings Shares Stage a Tentative Rebound After Steep Declines

August 24, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Insider Selling Spree Raises Questions at Procter & Gamble August 24, 2025
  • Oracle’s AI Ambition: Market Optimism Meets Investor Skepticism August 24, 2025
  • Activist Investor Targets Salesforce Amid Market Challenges August 24, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com